Ventricular septal defect medical therapy

Ventricular septal defect Microchapters
Home
Patient Information
Overview
Classification
Pathophysiology
Causes
Differentiating Ventricular Septal Defect from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography
Cardiac Catheterization
Treatment
Medical Therapy
Surgery
Ventricular septal defect post-surgical prognosis
ACC/AHA Guidelines for Surgical and Catheter Intervention Follow-Up
Prevention
ACC/AHA Guidelines for Reproduction
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Ventricular septal defect medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Ventricular septal defect medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Ventricular septal defect medical therapy
CDC on Ventricular septal defect medical therapy
Ventricular septal defect medical therapy in the news
Blogs on Ventricular septal defect medical therapy
Directions to Hospitals Treating Ventricular septal defect
Risk calculators and risk factors for Ventricular septal defect medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, MBBS [[2]]; Cafer Zorkun, M.D., Ph.D. [3]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [[4]]

ACC/AHA Guideline: Recommendation for Medical Therapy(DO NOT EDIT)

Class IIb

"1. Pulmonary vasodilator therapy may be considered for adults with VSDs with progressive/severe pulmonary vascular disease (refer to the National Guideline Clearinghouse [NGC] summary of the ACC/AHA guideline, Pulmonary Hypertension/Eisenmenger Physiology).(Level of Evidence: B) "

References

Template:WikiDoc Sources